Search

everythinglearnresearchcommunity

for

Search:↓

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Smad1 and Smad5 are essential for hair follicle development and stem cell sleepiness.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Tiny RNA molecules help control the growth of plant hairs.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Spironolactone plus finasteride reduces hirsutism more effectively.

Finasteride safely reduces excessive hair growth in women.

Created tablet similar to Avodart using γ-cyclodextrin and solubilizers.

Three cost-effective methods accurately measure finasteride in pharmaceuticals, better than current techniques.

Method measures tamsulosin and finasteride in medicine accurately.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.